SCHEMBL3566985

SCHEMBL3566985

C=C(C)C(=O)Oc1ccc2cc3cc(OC(=O)C(=C)C)ccc3cc2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.53
KMT2A Q03164 7/20 0.49
ATM Q13315 1/20 0.49
CA12 O43570 2/20 0.42
CA9 Q16790 2/20 0.42
MEN1 O00255 4/20 0.41
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
NCEH1 Q6PIU2 1/20 0.41
HTT P42858 1/20 0.41
TDP1 Q9NUW8 2/20 0.41
KDM4E B2RXH2 2/20 0.40
GLA P06280 1/20 0.40
POLB P06746 1/20 0.40
GAA P10253 1/20 0.40
FLT3 P36888 1/20 0.39
TSHR P16473 1/20 0.39
CA2 P00918 1/20 0.39
NPC1 O15118 1/20 0.39
CASP3 P42574 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15302662 1.00 ELANE (0.53) ELANEKMT2AATMCA12CA9
SCHEMBL2121980 0.96 ELANE (0.53) ELANEKMT2AATMCA12CA9
SCHEMBL803231 0.96 ELANE (0.56) ELANEKMT2AATMCA12CA9
SCHEMBL11746613 0.95 ELANE (0.57) ELANEKMT2AATMCA12CA9
SCHEMBL15357800 0.93 ELANE (0.50) ELANEKMT2AATMCA12CA9
SCHEMBL11963909 0.91 ELANE (0.49) ELANEKMT2AATMCA12CA9
SCHEMBL10014245 0.91 ELANE (0.51) ELANEKMT2AATMCA12CA9
SCHEMBL10014244 0.90 ELANE (0.47) ELANEKMT2AATMCA12CA9
SCHEMBL18432905 0.89 KDM4E (0.51) ELANEKMT2AATMMEN1MAPT
SCHEMBL36603 0.89 ELANE (0.58) ELANEKMT2AATMMEN1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230046964-A1 ALIGNMENT FILM, DISPLAY DEVICE, METHOD FOR PRODUCING DISPLAY DEVICE, LIQUID CRYSTAL ALIGNMENT AGENT, AND LIQUID CRYSTAL COMPOSITION SHARP KABUSHIKI KAISHA (JP) 2023-02-16 US disclosed
US-20200301213-A1 LIQUID CRYSTAL DISPLAY ELEMENT AND METHOD FOR MANUFACTURING SAME DIC CORPORATION (JP) 2020-09-24 US disclosed
US-10344214-B2 Liquid crystal display device and method for manufacturing the same DIC CORPORATION (JP) 2019-07-09 US disclosed
EP-2653501-B1 CROSSLINKABLE RESIN MOLDED BODY, AND LAMINATE ZEON CORP (JP) 2019-05-22 EP disclosed
US-20190086736-A1 LIQUID CRYSTAL DISPLAY DEVICE SHARP KABUSHIKI KAISHA (JP) 2019-03-21 US disclosed
EP-2955570-B1 LIQUID CRYSTAL DISPLAY ELEMENT AND MANUFACTURING METHOD FOR SAME DAINIPPON INK & CHEMICALS (JP) 2018-03-28 EP disclosed
US-20170321122-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME DIC CORPORATION (JP) 2017-11-09 US disclosed
US-20170321122-A1 LIQUID CRYSTAL DISPLAY DEVICE AND METHOD FOR MANUFACTURING THE SAME DIC CORPORATION (JP) 2017-11-09 US disclosed
US-9719017-B2 Liquid crystal display device and method for manufacturing the same DIC CORPORATION (JP) 2017-08-01 US disclosed
US-9719017-B2 Liquid crystal display device and method for manufacturing the same DIC CORPORATION (JP) 2017-08-01 US disclosed
US-20100053527-A1 LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR MANUFACTURING THE SAME AU OPTRONICS CORP. (TW) 2010-03-04 US disclosed
US-20100053527-A1 LIQUID CRYSTAL DISPLAY PANEL AND METHOD FOR MANUFACTURING THE SAME AU OPTRONICS CORP. (TW) 2010-03-04 US disclosed
US-20090324855-A1 LIQUID CRYSTAL DISPLAY PANEL AND COMPOSITION OF LIQUID CRYSTAL LAYER THEREOF AU OPTRONICS CORP. (TW) 2009-12-31 US disclosed
US-20090324855-A1 LIQUID CRYSTAL DISPLAY PANEL AND COMPOSITION OF LIQUID CRYSTAL LAYER THEREOF AU OPTRONICS CORP. (TW) 2009-12-31 US disclosed
US-20080236727-A1 Liquid crystalline medium and method for manufacturing liquid crystal display panel AU OPTRONICS CORP. (TW) 2008-10-02 US disclosed
US-20080236727-A1 Liquid crystalline medium and method for manufacturing liquid crystal display panel AU OPTRONICS CORP. (TW) 2008-10-02 US disclosed
US-20080179565-A1 Photosensitive monomer, liquid crystal material having the same, liquid crystal panel and method for manufacturing thereof by incorporating the same, and electro-optical device and method for manufacturing thereof by incorporating the same AU OPTRONICS CORP. (TW) 2008-07-31 US disclosed
US-20080179565-A1 Photosensitive monomer, liquid crystal material having the same, liquid crystal panel and method for manufacturing thereof by incorporating the same, and electro-optical device and method for manufacturing thereof by incorporating the same AU OPTRONICS CORP. (TW) 2008-07-31 US disclosed
US-20080179565-A1 Photosensitive monomer, liquid crystal material having the same, liquid crystal panel and method for manufacturing thereof by incorporating the same, and electro-optical device and method for manufacturing thereof by incorporating the same AU OPTRONICS CORP. (TW) 2008-07-31 US disclosed
CN-101013262-A Photo-sensitive monomer, liquid crystal material, liquid crystal panel and method of fabrication, photoelectric device and fabricating method thereof AU OPTRONICS CORP (CN) 2007-08-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080179565-A1 Photosensitive monomer, liquid crystal material having the same, liquid crystal panel and method for manufacturing thereof by incorporating the same, and electro-optical device and method for manufacturing thereof by incorporating the same LPO, PPOX, SCLY ELANE 658/4885KMT2A 1595/4885ATM 2488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.